Drug Shortage Report for WELLBUTRIN XL

Last updated on 2024-11-13 History
Report ID 240257
Drug Identification Number 02275090
Brand name WELLBUTRIN XL
Common or Proper name WELLBUTRIN XL
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) BUPROPION HYDROCHLORIDE
Strength(s) 150MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100's
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2024-10-10
Estimated end date 2024-11-13
Actual end date 2024-11-12
Shortage status Resolved
Updated date 2024-11-13
Company comments On Allocation - Covering Key Accounts
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2024-11-13 French Compare
v10 2024-11-13 English Compare
v9 2024-11-01 French Compare
v8 2024-11-01 English Compare
v7 2024-11-01 French Compare
v6 2024-11-01 English Compare
v5 2024-10-23 French Compare
v4 2024-10-23 English Compare
v3 2024-10-15 French Compare
v2 2024-10-15 English Compare
v1 2024-10-15 English Compare

Showing 1 to 11 of 11